[VYNE] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
03-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -27.55%
YoY- -22.19%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 3,269 11,688 1,750 0 0 0 0 -
PBT -24,713 -167,699 -40,233 -21,498 -16,855 -16,477 -18,873 19.63%
Tax 1 -259 728 -52,379 0 0 0 -
NP -24,714 -167,440 -40,233 -21,498 -16,855 -16,477 -18,873 19.63%
Tax Rate - - - - - - - -
Total Cost 27,983 179,128 41,983 21,498 16,855 16,477 18,873 29.93%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -756.01 -1,432.58 -2,299.03 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -10.61 -86.95 -68.15 -64.36 -50.66 -49.65 -58.35 -67.80%
EPS Diluted -10.61 -86.95 -68.15 -64.36 -50.66 -49.65 -58.35 -67.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.